SCHEMBL20141744

SCHEMBL20141744

CC(C)(C)OC(=O)N=S(C)(=O)c1c(F)cccc1N1CCN(C(=O)O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALOX15 P16050 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 6/20 0.39
ALDH1A1 P00352 3/20 0.39
TSHR P16473 3/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPK1 P28482 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20142150 0.91 TP53 (0.44) POLBCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL20129699 0.86 HTR6 (0.41) SMN1; SMN2ALDH1A1
SCHEMBL20129702 0.82 PKM (0.37) HTTMAPK1NPSR1HSD17B10LMNA
SCHEMBL20149915 0.81 SCN9A (0.35) POLBSMN1; SMN2ALDH1A1LMNA
SCHEMBL20129736 0.81 SCN9A (0.35) POLBSMN1; SMN2ALDH1A1LMNA
SCHEMBL20129735 0.81 SCN9A (0.35) POLBSMN1; SMN2ALDH1A1LMNA
SCHEMBL22693287 0.77 STS (0.45) SMN1; SMN2HTTRAB9AMAPK1NPSR1
SCHEMBL20140841 0.76 CYP1A2 (0.52) POLBKDM4EALOX15CYP1A2CYP2C9
SCHEMBL21360411 0.75 SMARCA2 (0.47) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL21360400 0.72 HSD11B1 (0.38) POLBSMN1; SMN2ALDH1A1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR POLB 2449/4885KDM4E 253/4885ALOX15 4206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.